Research strategies, budgeting, preliminary data, and commercialization.
In this part, we will review the Research Strategy sections: Significance, Innovation and Approach. Budgeting will be discussed in detail. We will also review the importance of advisory committees, academic collaborators and the value of Preliminary Data. We will wrap up with the structure and requirements for the Commercialization section.
Dr. O’Halloran has more than 17 years of experience with the SBIR program and has received funding from the National Institute on Aging (NIA), National Institute of Mental Health (NIMH) and the National Institute on Neurological Diseases and Stroke (NINDS). He has served as principal investigator on more than 20 grants, totaling more than $10M. He has also served as a selected reviewer for these same agencies for over a decade and is intimately familiar with the 5-axis proposal scoring processes and dynamics, upon which funding depends. As a deeply experienced reviewer, he is highly skilled on how best to emphasize a proposal’s strengths, avoid common pitfalls and tune proposals for review.
Presented in Partnership with:
ScienceDocsis a U.S. based, comprehensive scientific and medical research support provider that has been leading the industry since 2004. Their core services include:
ScienceDocs work with individual researchers, groups, publishers, universities, businesses and governmental agencies around the world with content in all physical, biological and social science disciplines. Their staff consists of over 150 seasoned PhD-level/veteran editors, writers and grant consultants, startup experts, biostatisticians and epidemiologists, as well as an extensive in-house and contracted translation staff exceeding 1500 specialized translators into and out of English and all major languages. ScienceDocs are, in essence, your peers…they understand your needs and are here to help you.